Kilburg: We have a global sense of urgency into biotech we've never seen before

Jeff Kilburg of KKM Financial discusses the reaction to potential promising results from Gilead's study involving its drug to possibly treat COVID-19, and a return of the trend of large companies driving trade in the broader markets.